Vascular endothelial growth factor receptor (VEGFR) can be expressed on the cell surface of several tumor types [47], and we have shown that a high glucose level can enhance VEGFR2 mRNA expression by suppressing miR-16 expression. The gene discussed is KDR; the disease is neoplasm.